Clinical trial
Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
NCT00307840 · Papageorgiou General Hospital, Other · Completed
Key facts
| NCT number | NCT00307840 |
|---|---|
| Title | Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism |
| Official title | Initial Dosing of Paricalcitol Based on iPTH Parathyroid Hormone Levels in Hemodialysis Patients With Secondary Hyperparathyroidism |
| Lead sponsor | Papageorgiou General Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism |
| Intervention type | Drug |
| Interventions | paricalcitol |
| Start date | Feb 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Mar 28, 2006 |
| Last update posted | Mar 28, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: